Role of regulatory T cells in allergy and asthma

Current Opinion in Immunology

Volumn 15, Issue 6, 2003, Pages 627-633

  Akbari, Omid ^a   Stock, Philippe ^a   DeKruyff, Rosemarie H ^a   Umetsu, Dale T ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; INTERLEUKIN DERIVATIVE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC ASTHMA; ALLERGIC ENCEPHALOMYELITIS; ALLERGY; ANTIGEN SPECIFICITY; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; COLITIS; DIABETES MELLITUS; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NONHUMAN; REVIEW; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TH3 CELL; THYMUS; TR CELL; TUMOR IMMUNITY;

EID: 0242491040     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2003.09.012     Document Type: Review

References (78)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25), breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1995;1151-1164.
2. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:1996;387-396.
3. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:1999;255-281.
4. Umetsu D., McIntire J., Macaubas C., Akbari O., DeKruyff R. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:2002;715-720.
5. Hansen G., Berry G., DeKruyff R.H., Umetsu D.T. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:1999;175-183.
6. Bach J. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:2002;911-920.
7. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
8. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
9. Katagiri K., Zhang-Hoover J., Mo J., Stein-Streilein J., Streilein J. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J. Immunol. 169:2002;84-89.
10. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:2000;4848-4853.
11. R cells and the ICOS-ICOS ligand signaling pathway are critically involved in respiratory tolerance and in downregulating pulmonary inflammation in an animal model of asthma.
12. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J. Immunol. 155:1995;1151-1164.
13. Powrie F., Correa-Oliveira R., Mauze S., Coffman R.L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:1994;589-600.
14. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:2001;1285-1294.
15. + T-cell mediated suppression, resulting in organ-specific autoimmune disease.
16. + regulatory T cells.
17. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003, 3:199-210.
18. Belkaid Y., Piccirillo C., Mendez S., Shevach E., Sacks D. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 420:2002;502-507.
19. Jordan M.S., Boesteanu A., Reed A.J., Petrone A.L., Holenbeck A.E., Lerman M.A., Naji A., Caton A.J. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:2001;301-306.
20. + T cells by at least two distinct mechanisms: the induction of co-stimulatory molecules on DCs and the production of IL-6.
21. Stockinger B., Barthlott T., Kassiotis G. T cell regulation: a special job or everyone's responsibility? Nat. Immunol. 2:2001;757-758.
22. McHugh R.S., Shevach E.M. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:2002;5979-5983.
23. Barthlott T., Kassiotis G., Stockinger B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197:2003;451-460 This work is important, as the authors elegantly show that regulatory activity is correlated with high homeostatic expansion potential, rather than expression of markers such as CD25. T cells capable of preventing immune pathology, for example, the transgenic T cells capable of preventing immune pathology express higher than average levels of CD5, an indicator of avidity for self-MHC peptide complexes. Finally, the authors propose that the dysregulated expansion of potentially pathogenic T cells in a lymphopenic environment can be prevented by members of the naïve T-cell repertoire, irrespective of their specificity, as a side-effect of their response to homeostatic and antigenic stimulation.
24. + T cells are two distinct subsets of regulatory cells with different cytokine profiles.
25. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A.H. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196:2002;255-260.
26. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:2001;629-644.
27. Dieckmann D., Bruett C.H., Ploettner H., Lutz M.B., Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196:2002;247-253.
28. Wilson S.B., Delovitch T.L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3:2003;211-222 In this review, the authors highlight the data supporting the role of NKT cells in the regulation of autoimmune diseases and cancer.
29. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:1998;177-181.
30. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 413:2001;531-534.
31. Heller F., Fuss I.J., Nieuwenhuis E.E., Blumberg R.S., Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 17:2002;629-638.
32. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., Carbone D.P., Paul W.E., Berzofsky J.A. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1:2000;515-520.
33. Matsuda J.L., Gapin L., Sidobre S., Kieper W.C., Tan J.T., Ceredig R., Surh C.D., Kronenberg M. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 3:2002;966-974 In this paper, the authors show that the expansion of Vα14i NKT cells in lymphopenic mice is not dependent on CD1d expression, and is unaffected by the presence of host NKT cells. These results also suggest a role for IL-15 and IL-7 in the expansion and survival of NKT cells.
34. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1998;1521-1528.
35. Platts-Mills T., Vaughan J., Squillace S., Woodfolk J., Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet. 357:2001;752-756.
36. Ownby D.R., Johnson C.C., Peterson E.L. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA. 288:2002;963-972.
37. Braun-Fahrlander C., Gassner M., Grize L., Neu U., Sennhauser F.H., Varonier H.S., Vuille J.C., Wuthrich B. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss study on childhood allergy and respiratory symptoms with respect to air pollution. Clin. Exp. Allergy. 29:1999;28-34.
38. Riedler J., Braun-Fahrlander C., Eder W., Schreuer M., Waser M., Maisch S., Carr D., Schierl R., Nowak D., von Mutius E. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 358:2001;1129-1133.
39. Braun-Fahrlander C., Riedler J., Herz U., Eder W., Waser M., Grize L., Maisch S., Carr D., Gerlach F., Bufe A., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347:2002;869-877.
40. Gambineri E., Torgerson T., Ochs H. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15:2003;430-435.
41. Hansen G., McIntire J.J., Yeung V.P., Berry G., Thorbecke G.J., Chen L., DeKruyff R.H., Umetsu D.T. CD4+ Th cells engineered to produce latent TGF-b1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105:2000;61-70.
42. Nakao A., Miike S., Hatano M., Okumura K., Tokuhisa T., Ra C., Iwamoto I. Blockade of transforming growth factor b/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J. Exp. Med. 192:2000;151-158.
43. Oh J.W., Seroogy C.M., Meyer E.H., Akbari O., Berry G., Fathman C.G., DeKruyff R.H., Umetsu D.T. CD4 T helper cells engineered to produce IL-10 reverse allergen-induced airway hyperreactivity and inflammation. J. Allergy Clin. Immunol. 110:2002;460-468.
44. Stampfli M.R., Cwiartka M., Gajewska B.U., Alvarez D., Ritz S.A., Inman M.D., Xing Z., Jordana M. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am. J. Respir. Cell Mol. Biol. 21:1999;586-596.
45. Tsitoura D.C., DeKruyff R.H., Lamb J.R., Umetsu D.T. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J. Immunol. 163:1999;2592-2600.
46. Seymour B.W., Gershwin L.J., Coffman R.L. Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J. Exp. Med. 187:1998;721-731.
47. McMenamin C., Pimm C., McKersey M., Holt P.G. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science. 265:1994;1869-1871.
48. McMenamin C., Holt P.G. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J. Exp. Med. 178:1993;889-899.
49. Lahn M., Kanehiro A., Takeda K., Joetham A., Schwarze J., Kohler G., O'Brien R., Gelfand E.W., Born W., Kanehio A. Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells. Nat. Med. 5:1999;1150-1156.
50. Zuany-Amorim C., Ruffie C., Haile S., Vargaftig B.B., Pereira P., Pretolani M. Requirement for γδ T cells in allergic airway inflammation. Science. 280:1998;1265-1267.
51. Schwarze J., Cieslewicz G., Joetham A., Ikemura T., Hamelmann E., Gelfand E.W. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J. Immunol. 162:1999;4207-4211.
52. Hoyne G.F., Askonas B.A., Hetzel C., Thomas W.R., Lamb J.R. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int. Immunol. 8:1996;335-342.
53. Hoyne G.F., Tan K., Corsin-Jimenez M., Wahl K., Stewart M., Howie S.E., Lamb J.R. Immunological tolerance to inhaled antigen. Am. J. Respir. Crit. Care Med. 162:2000;S169-S174.
54. Tsitoura D.C., Blumenthal R.L., Berry G., DeKruyff R.H., Umetsu D.T. Mechanisms preventing allergen-induced airways hyperreactivity: role of immune deviation and tolerance. J. Allergy Clin. Immunol. 106:2000;239-246.
55. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells secreting IL-10 mediate T cell tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:2001;725-731.
56. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:2001;769-779.
57. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238.
58. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:2003;685-711.
59. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.
60. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 18:2003;605-617.
61. ••].
62. + DCs and induces the production of the Th2-attracting chemokines TARC (for thymus and activation-regulated chemokine) and MDC (for macrophage-derived chemokine). TSLP-activated DCs prime naïve Th cells to produce the proallergic cytokines IL-4, IL-5, IL-13 and TNF, and downregulate IL-10 and IFN-γ.
63. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1997;1739-1745.
64. Zuany-Amorim C., Sawicka E., Manlius C., Le Moine A., Brunet L.R., Kemeny D.M., Bowen G., Rook G., Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:2002;625-629.
65. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:2002;1645-1651.
66. McGuirk P., McCann C., Mills K. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:2002;221-231.
67. Matricardi P., Rosmini F., Riondino S., Fortini M., Ferrigno L., Rapicetta M., Bonini S. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ. 320:2000;412-417.
68. McIntire J.J., Umetsu S.E., Akbari O., Potter M., Kuchroo V.K., Barsh G.S., Freeman G.J., Umetsu D.T., DeKruyff R.H. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2:2001;1109-1116.
69. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 357:2001;1076-1079.
70. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:2003;582-588.
71. Smiley S.T., Kaplan M.H., Grusby M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science. 275:1997;977-979.
72. Brown D., Fowell D., Corry D., Wynn T., Moskowitz N., Cheever A., Locksley R., Reiner S. Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184:1996;1295-1304.
73. Herrick C.A., Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3:2003;405-412.
74. Weiner H.L. The mucosal milieu creates tolerogenic dendritic cells and Tr1 and Th3 regulatory cells. Nat. Immunol. 2:2001;671-672.
75. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:2000;4848-4853.
76. Suto A., Nakajima H., Kagami S.I., Suzuki K., Saito Y., Iwamoto I. Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am. J. Respir. Crit. Care Med. 164:2001;680-687.
77. Hadeiba H., Locksley R. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 170:2003;5502-5510.
78. Francis J., Till S., Durham S. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111:2003;1255-1261.